A 4550
Referred to committee
Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.
- New Jersey
- House / Assembly
- Introduced Mar 10, 2026
- Session 222
Official Bill Page
Loading official bill page…
This state’s bills aren’t available here
New Jersey’s legislature doesn’t allow its bill pages to be shown on other sites. You can read the full bill on the official page.
View on official siteLegislative Timeline
1 action-
Introduced, Referred to Assembly Financial Institutions and Insurance Committee